Hence charts at this juncture...don't mean much.
Fundamentals all exposed via that interview.......and to a North American audience. They basically don't know too much beyond there circle unless pressed....they're now pressed! Cantor's done a tidy job....plus those interested private investors.
And what an interview! Too many moving parts to illuminate upon to source down to one golden point..pending your term of holding. Carrier's massive tonnage potential did it for me, and that's give given there's more potentially from Roche....
Plus Tin and Tantalum as a minor play....and most of all the expansion of DFS,/BFS numbers in an upward projection....
The MLs are the FIRST play to be let unleashed before the REAL numbers hit us. Thats how I read this interview.
Bring on BFS...
AVZ chart, page-11649
-
- There are more pages in this discussion • 1,697 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online